CRChristopher Roark

Christopher Roark

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christopher Roark has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pre-existing intracranial arterial stenosis independently predicts delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

    by Ross Moseley, Ahmed Helal, Mohamed Salem, Yan Zhou, Hayley Granberg, Daron Assatoury, Zach Folzenlogen, Christopher Roark, Joshua Seinfeld, David Case

    Purpose Delayed cerebral ischemia (DCI) remains a significant cause of morbidity and mortality following aneurysmal subarachnoid hemorrhage (aSAH). Despite identification of numerous predictors, risk remains variable even among patients with similar hemorrhage severity suggesting presence of unrecognized modifiers. One factor receiving little attention is intracranial arterial disease (ICAD): stenosis and calcification. We aim to examine their additive impacts to known modifiers. Methods We analyzed 526 patients with aSAH treated at a single, tertiary care center between 2015 and 2025. DCI was defined as new neurologic deficits and/or new cerebral infarction ≥ 48 h from hemorrhage not explained by other etiologies. Stenosis (≥ 25% of luminal diameter) and calcification (CTA hyperdensity ≥ 100 HU) were assessed in all arteries including and distal to the petrous ICA on admission CTA. Multivariable logistic regressions were used to determine independent associations with DCI. For easy clinical applicability, ICAD was dichotomized as presence vs. absence. Results Among 526 patients with aSAH, 440 survived ≥ 48 h and were included (median age = 56 IQR [45–64], 63.7% female). 132/440 (30.1%) developed DCI. DCI was associated with significantly worse outcomes (median mRS DCI: 4, No DCI 2, p < 0.001). Stenosis, not calcification, was an independent predictor of DCI (aOR:3.556, 95%CI: 1.90–6.65, p < 0.001). Vasospasm significantly correlated with DCI (OR:5.89, 95%CI: 3.62–9.57, p < 0.001), and more common in patients with stenosis (aOR:2.391 95%CI: 1.240–4.608, p < 0.001). Conclusion Pre-existing ICAD confers substantial, independent DCI risk after aSAH, enhancing rather than competing with traditional predictors. This suggests that baseline cerebrovascular integrity meaningfully predicts ischemic vulnerability following hemorrhage.

  • Clinical Decision Support for Patients Presenting With Large Vessel Occlusion

    by Jennifer R. Simpson, Russell J. VanCoevering, Kerri Jeppson, David Case, Joshua Seinfeld, Christopher Roark, Sharon N. Poisson

    A single center had a collaborative, multidisciplinary review to determine how to best implement new acute ischemic stroke trials involving large vessel occlusions. A flow diagram process map was created for clinical decision support. Patients were divided into four groups based upon size of infarct and timing of presentation. The process map, available in the electronic health record (EHR) for clinicians to reference, guides the selection of patients for endovascular therapy with neuroimaging. In addition, the process map offers guidance for discussions with families and patients experiencing large vessel occlusions with both small and large core infarcts. This manuscript describes the process of creating the process map through a multidisciplinary review and discussion, with points of controversy and how these were addressed.

  • Open Access

    O-035 Endovascular treatment of cerebral venous thrombosis involving the deep venous system

    by B Morel, J Hoffman, Z Folzenlogen, C Roark, J Seinfeld, D Case

    Introduction Cerebral venous thrombosis (CVT) accounts for a small percentage of all strokes. While the superior sagittal sinus is the most common location, a subset of CVT involves the deep venous system - the internal cerebral veins, vein of Galen, basal vein of Rosenthal, and thalamostriate veins. Deep CVT can cause thalamic and basal ganglia edema, hemorrhage, and strokes, resulting in disorders of consciousness and subsequent death or dependency. While anticoagulation is the mainstay therapy for CVT, patients with worsening neurologic examinations, strokes, or intracerebral hemorrhage (ICH) may benefit from endovascular therapy and recanalization of the affected vessels. This is complicated in the deep veins by difficult catheterization due to small, fragile vessels. We hypothesize that endovascular treatment of the superficial venous sinuses or the straight sinus alone, without catheterization of deep veins, can result in apparent recanalization of the deep venous sinuses resulting in improved radiologic and clinical outcomes. Materials/Methods We queried our interventional radiology (IR) database from January 1, 2010 - February 23, 2021 for patients with CVT. This returned a total of 5599 patient encounters containing the search terms, of which 43 had undergone endovascular treatment for CVT. 31 of these patients had venous thrombosis in the superficial sinuses only, while 12 patients had venous thrombosis involving the deep venous system. Results The 12 patients whose CVT involved deep veins and who underwent endovascular intervention had the following demographics. All 12 patients underwent intervention due to clinical and/or radiographic worsening despite adequate heparin infusions. 4 patients underwent catheterization of the straight sinus. All other interventions were in the superficial venous sinuses only. All 12 patients with deep venous involvement ultimately had recanalization of the deep system. Modified Rankin scale at discharge was an average of 2.2 (range 0-5). Conclusions Although deep venous involvement of CVT is uncommon, these patients are at risk of quickly becoming critically ill with an elevated rate of death or dependency. Although these patients may develop stroke, hemorrhage, or neurologic decline prompting consideration of endovascular therapy, the deep cerebral venous system is not easily accessible with catheters due to small lumens and risk of perforation. It has been proposed that deep cerebral veins may have a higher chance of recanalization if venous thrombus burden is reduced in other parts of the dural venous sinuses. Current literature has not fully explored the association between endovascular treatment of the superficial dural venous sinuses and deep venous flow. Our study shows that endovascular recanalization of the superficial venous sinuses and/or straight sinus can subsequently result in recanalization of the deep veins and improve radiologic and clinical outcomes. Prospective trials are still needed to provide further evidence of safety and efficacy. Disclosures B. Morel: None. J. Hoffman: None. Z. Folzenlogen: None. C. Roark: None. J. Seinfeld: None. D. Case: None.

  • Technical Nuances and Outcomes of Telescoping Pipeline Flow Diverters: A Multicenter Study

    by Cordell M. Baker, Joshua C. Hunsaker, Zach A. Folzenlogen, Glenn L. Pride, David E. Case, Babu G. Welch, Jonathan A. White, Christopher D. Roark, Andrew C. White, Joshua Seinfeld, et al.

    BACKGROUND: “Telescoping” multiple overlapping Pipeline Embolization Devices (PEDs; Medtronic) has increased their utility by allowing for more impermeable coverage and providing the ability to off-set landing zone sites and extend treatment constructs. OBJECTIVE: To consider the technical nuances and challenges of telescoping PEDs for the treatment of intracranial aneurysms. METHODS: Databases from 3 U.S. academic neurovascular centers were retrospectively queried to identify patients with intracranial aneurysms treated with multiple PED constructs. Data on patient and aneurysm characteristics, as well as outcomes including Raymond-Roy occlusion classification, modified Rankin Scale score, and complications, were gathered. RESULTS: Forty-six patients had 48 intracranial aneurysms treated, including 16 (33%) in whom placement of telescoping PEDs was planned. Fourteen (30%) patients presented with a ruptured aneurysm. Twenty-one aneurysms (44%) were treated with proximal extension, 13 (27%) with distal extension, and 14 (29%) with PED placement inside one another. Thirty (70%) patients had complete aneurysm occlusion at follow-up. Two (4%) patients had to be retreated. Three patients with unruptured and 1 with ruptured aneurysm had a permanent intraprocedural complication. We present descriptive cases illustrating PEDs that were placed inside one another, proximally, distally, and to improve wall apposition because of vessel tortuosity. CONCLUSION: Our data indicate a higher than expected complication rate that is likely because of the technical complexity of these cases. The case illustrations presented demonstrate the indications and challenging aspects of telescoping PEDs.


  • Open Access

    Untangling the Modern Treatment Paradigm for Unruptured Brain Arteriovenous Malformations

    by Brent C. Morel, Blake Wittenberg, Jessa E. Hoffman, David E. Case, Zach Folzenlogen, Christopher Roark, Joshua Seinfeld

    Brain arteriovenous malformations (AVMs) often present treatment challenges. Patients with unruptured AVMs must consider not only whether they want to be treated, but what treatment modality they would prefer. Vascular neurosurgeons, neurointerventional surgeons, and stereotactic radiosurgeons must in turn guide their patients through the most appropriate treatment course considering the risk of AVM rupture, an individual AVM’s characteristics, and patient preferences. In this review we will look at how the clinical trial “A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA)” has influenced the approach to unruptured brain AVMs and the treatment modalities available to clinicians to deal with these formidable lesions.


  • Open Access

    ReviewR: A light-weight and extensible tool for manual review of clinical records

    by David A. Mayer, Luke V. Rasmussen, Christopher D. Roark, Michael G. Kahn, Lisa M. Schilling, Laura K. Wiley

    OBJECTIVES Manual record review is a crucial step for electronic health record (EHR)-based research, but it has poor workflows and is error prone. We sought to build a tool that provides a unified environment for data review and chart abstraction data entry. MATERIALS AND METHODS ReviewR is an open-source R Shiny application that can be deployed on a single machine or made available to multiple users. It supports multiple data models and database systems, and integrates with the REDCap API for storing abstraction results. RESULTS We describe two real-world uses and extensions of ReviewR. Since its release in April 2021 as a package on CRAN it has been downloaded 2,204 times. DISCUSSION AND CONCLUSION ReviewR provides an easily accessible review interface for clinical data warehouses. Its modular, extensible, and open source nature afford future expansion by other researchers. LAY SUMMARY When doing research using data from electronic health records (EHRs), data may need to be extracted by hand, either to perform the study or to ensure its accuracy. However many researchers can’t access the EHR for this purpose. Even when researchers have access, they must flip between their review list, the EHR, and the location they are recording the results of their review, which is difficult and can cause errors. We developed a software application, ReviewR, to make this process easier and less error prone and have used it in two real-world projects.

  • Predictors of 90-Day Readmission Rate After Unruptured Intracranial Aneurysm Repair

    by Christopher D. Roark, Cheryl Beseler, Laura K. Wiley, David Case, Zach Folzenlogen, Patrick Hosokawa, Joshua Seinfeld


  • Open Access

    Assessing the Utility and Accuracy of ICD10-CM Nontraumatic Subarachnoid Hemorrhage Codes for Intracranial Aneurysm Research

    by Christopher Roark, Melissa P. Wilson, Sheila Kubes, David Mayer, Laura K. Wiley

    Background: The 10th revision of International Classification of Disease, Clinical Modification (ICD10-CM) increased the number of codes to identify nontraumatic subarachnoid hemorrhage from one to twenty-two. ICD10-CM codes are able to specify the location of aneurysms causing subarachnoid hemorrhage (aSAH), however it is not clear how frequently or accurately these codes are being used in practice. Objective: To systematically evaluate the usage and accuracy of location-specific ICD10-CM codes for aSAH. Methods: We extracted all uses of ICD10-CM codes for nontraumatic subarachnoid hemorrhage (I60.x) during the first three years following the implementation of ICD10-CM from the billing module of the EHR for UCHealth. For those codes that specified aSAH location (I60.0-I60.6), EHR documentation was reviewed to determine whether there was an active aSAH, any patient history of aSAH, or unruptured intracranial aneurysm/s and the locations of those outcomes. Results: Between October 1, 2015 – September 30, 2018, there were 3,119 instances of nontraumatic subarachnoid hemorrhage ICD10-CM codes (I60.00-I60.9), of which 297 (9.5%) code instances identified aSAH location (I60.0-I60.6). These codes accurately identified current aSAH (64%), any patient history of aSAH (84%), and any patient history of intracranial aneurysm (87%). The accuracy of identified outcome location was 53% in current aSAH, 72% for any history of aSAH, and 76% for any history of an intracranial artery. Conclusions: Researchers should use ICD10-CM codes with caution when attempting to detect active aSAH and/or aneurysm location.